The framework has had a lukewarm reaction, with trade association EFPIA saying the policies are “not strong enough”.

The agency is approaching the new overhaul as a chance to reshape drug regulations in the European Union.

Global CRISPR Technology Market OverviewThe global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This ...

The EU pharmaceutical reform aims to improve drug accessibility, affordability, and innovation, addressing market protection and antimicrobial resistance. Co-legislators in Europe have reached a ...

Donna Conroy, MS is Founder/CEO of SciMar ONE, Inc. a technology company building AI-based SaaS solutions for the pharmaceutical industry. The pharmaceutical industry (or pharma for short) has ...

Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will ...

The worlds of technology and entrepreneurship are captivated by recent advances in generative AI and large language models (LLMs). But if the future has arrived, as science fiction writer William ...

The UK's 14.5% drug rebate reduction may help to quell souring pharma sentiments, which stem from the nation's low spending on innovative drugs.

Since the beginning of 2022, the tech industry has laid off more than 78,000 employees, according to tracker Layoffs.fyi, with startups and Big Tech firms alike (including Snap, Tesla, Coinbase, ...

In a dramatic change to Australian patent law, Australia's Full Federal Court has just held that patents for pharmaceutical formulations are not eligible for patent term extensions ( PTE ): Otsuka ...

InnoCan Pharma ( ($TSE:INNO) ) has provided an announcement. Innocan Pharma has announced the public filing of an amended ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...